1.
Li X, He J, Song C. Research Progress on the CDK4/6 Signaling Pathway and Clinical Application of Its Inhibitors in HR+/HER2- Breast Cancer. Health Nexus [Internet]. 2025 Nov. 15 [cited 2026 Apr. 7];1:31-7. Available from: https://test.journals.panorama-sg.com/index.php/HealthNexus/article/view/148